Abstract
We are interested in imaging cell death in vivo using annexin V radiolabeled with I-124. In this study, [I-124]4IB-annexin V and [I-124]4IB-ovalbumin were made using [I-124]N-hydroxysuccinimdyl-4-iodobenzoate prepared by iododestannylation of N-hydroxysuccimmidyl-4-(ttributystannyl)benzoate. [I-124]4IB-annexin V binds to phosphatidylserine-coated microliter plates and apoptotic Jurkat cells and accumulates in hepatic apoptotic lesions in mice treated with anti-Fas antibody, while [I-124]4IB-ovalbumin does not. In comparison with I-124-annexin V,[I-124]4IB-annexin V has a higher rate of binding to phospliatidylserine in vitro, a higher kidney and urine uptake, a lower thyroid and stomach content uptake, greater plasma stability and a lower rate of plasma clearance. Binding of radioactivity to apoptotic cells relative to normal cells in vitro and in vivo appears to be lower for[I-124]4IB-annexin V than for I-124-annexin V.
Original language | English |
---|---|
Pages (from-to) | 403-413 |
Number of pages | 11 |
Journal | Nuclear Medicine and Biology |
Volume | 32 |
Issue number | 4 |
DOIs | |
Publication status | Published - May 2005 |
Keywords
- apoptosis annexin v molecular imaging positron emission tomography iodine-124 positron-emission-tomography acute myocardial-infarction flow-cytometric detection programmed cell-death in-vivo detection phosphatidylserine expression binding-properties imaging apoptosis tumor response pet